Digital Toolkit for the Maternal RSV Vaccine
Access Resources
About
This is a digital toolkit for the maternal RSV vaccine, which helps protect babies from severe RSV disease. It includes decision guides and videos about the vaccine's safety and timing. The Pfizer Abrysvo vaccine is recommended for pregnant people between 32-36 weeks during RSV season to prevent infant hospitalizations. If not vaccinated, babies can receive nirsevimab after birth. The toolkit also provides information on where to get vaccinated and costs involved, with assistance programs available for those uninsured. Additionally, it outlines a code of conduct for SMFM meetings to ensure respectful behavior among participants.
Tags
More like this
The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.